Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
Kamada Expands Biosimilar Portfolio With Commercial Launch Of Two Additional New Products In Israel, Adding To Existing Portfolio Of Two Products
Lilach Asher Topilsky At Kamada Secures Company Stock Options: $166K Acquired
Significant Move: Ishay Davidi Invests $152K In Kamada Stock Options
Witness A Substantial Acquisition As Uri Botzer Acquires $138K In Kamada Stock Options
Strategic Investment: Uri Botzer Boosts Portfolio With $148K In Kamada Stock Options
Significant Move: Ishay Davidi Invests $162K In Kamada Stock Options
Director At Kamada Acquires Company Stock Options Worth $162K
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth
Insider Decision Making Waves At Kamada: Boris Gorelik Exercises Options, Realizing $0
Big News: Lilach Payorski Adds $136K In Kamada Stock Options Io Portfolio
Amir London Makes Strategic Play: Invests $1.80M In Kamada Stock Options
Capitalizing On Growth Prospects, David Tsur Acquires A Substantial $59K In Kamada Stock Options
Strategic Move: Eran Nir Acquires Kamada Stock Options Worth $173K
Major Acquisition Alert: Assaf Itshayek Acquires $80K In Kamada Stock Options
Witness A Substantial Acquisition As Benjamin Dekel Acquires $80K In Kamada Stock Options
Capitalizing On Growth Prospects, Hanni Neheman Acquires A Substantial $115K In Kamada Stock Options
Chaime Orlev Seizes Opportunity: Acquires $413K Worth Of Kamada Stock Options
Leon Recanati Seizes Opportunity: Acquires $154K Worth Of Kamada Stock Options
Nir Livneh Executes Major Move: Acquires $171K In Kamada Stock Options
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
